<! -- Pour avoir les accordéons fermés par défaut -->

Recent Publications

Articles

More references

Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa.

Duncan L, Yilmaz Z, Gaspar H, Walters R, Goldstein J, Anttila V, Bulik-Sullivan B, Ripke S; Eating Disorders Working Group of the Psychiatric Genomics Consortium (Pantel J); Thornton L, Hinney A, Daly M, Sullivan PF, Zeggini E, Breen G, Bulik CM. Am J Psychiatry. 2017 Sep 1;174(9):850-858.

 

BDNF During Withdrawal.

Geoffroy H, Noble F. Vitam Horm. 2017;104:475-496.

 

Response of Htr3a knockout mice to antidepressant treatment and chronic stress.

Martin V, Riffaud A, Marday T, Brouillard C, Franc B, Tassin JP, Sevoz-Couche C, Mongeau R, Lanfumey L. Br J Pharmacol. 2017 Aug;174(15):2471-2483.

 

Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence.

Kelaï S, Ramoz N, Moalic JM, Noble F, Mechawar N, Imbeaud S, Turecki G, Simonneau M, Gorwood P, Maussion G. Addict Biol. 2018 Jan;23(1):448-460.

 

Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine.

Morisot N, Monier R, Le Moine C, Millan MJ, Contarino A. Br J Pharmacol. 2018 May;175(9):1504-1518.

 

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine.

Noble F, Marie N. Front Psychiatry. 2019 Jan 18;9:742.

 

Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain.

Van Steenwinckel J, Schang AL, Krishnan ML, Degos V, Delahaye-Duriez A, Bokobza C, Csaba Z, Verdonk F, Montané A, Sigaut S, Hennebert O, Lebon S, Schwendimann L, Le Charpentier T, Hassan-Abdi R, Ball G, Aljabar P, Saxena A, Holloway RK, Birchmeier W, Baud O, Rowitch D, Miron V, Chretien F, Leconte C, Besson VC, Petretto EG, Edwards AD, Hagberg H, Soussi-Yanicostas N, Fleiss B, Gressens P. Brain. 2019 Dec 1;142(12):3806-3833.

 

Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa.

Watson HJ, Yilmaz Z, Thornton LM, Hübel C, Coleman JRI, Gaspar HA, Bryois J, Hinney A, Leppä VM, Mattheisen M, Medland SE, Ripke S, Yao S, Giusti-Rodríguez P; Anorexia Nervosa Genetics Initiative; Hanscombe KB, Purves KL; Eating Disorders Working Group of the Psychiatric Genomics Consortium: Pantel J, Nat Genet. 2019 Aug;51(8):1207-1214.

 

Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia Nervosa.

Walton E, Hibar D, Yilmaz Z, Jahanshad N, Cheung J, Batury VL, Seitz J, Bulik CM; PGC-ED; ENIGMA Genetics Working Group (Pantel J); Thompson PM, Ehrlich S. Mol Neurobiol. 2019 Jul;56(7):5146-5156.

 

Associations Between Attention-Deficit/Hyperactivity Disorder and Various Eating Disorders: A Swedish Nationwide Population Study Using Multiple Genetically Informative Approaches.

Yao SY, et al. Genetics Working Group (Pantel J). Biol Psychiatry. 2019 Oct 15;86(8):577-586.

 

Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.

Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address: ; Cross-Disorder Group of the Psychiatric Genomics Consortium (Pantel J). Cell. 2019 Dec 12;179(7):1469-1482.e11.

 

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Busserolles J, Ben Soussia I, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, Eschalier A, Lolignier S. Br J Pharmacol. 2020 Oct;177(20):4782-4795.

 

Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonists.

Camacho E, Marie N, Dupas Q, Martel C, Nowoczyn M, Elie N, Rochais C, Töth G, Allouche S. Neuropharmacology. 2020 Nov 15;179:108286.

 

Histological and Behavioral Evaluation after Traumatic Brain Injury in Mice: A Ten Months Follow-Up Study.

Leconte C, Benedetto C, Lentini F, Simon K, Ouaazizi C, Taib T, Cho A, Plotkine M, Mongeau R, Marchand-Leroux C, Besson VC. J Neurotrauma. 2020 Jun 1;37(11):1342-1357.

 

Effects of Alcohol and Cocaine in a Mutant Mouse Model of Predisposition to Post-Traumatic Stress Disorder.

Paizanis E, Crotti M, Petit A, Règue M, Beray-Berthat V, Noble F, Lanfumey L, Mongeau R. Front Pharmacol. 2020 May 8;11:623.

 

Sex-linked roles of the CRF1 and the CRF2 receptor in social behavior.

Piccin A, Contarino A. J Neurosci Res. 2020 Aug;98(8):1561-1574.

 

Long-lasting pseudo-social aggressive behavior in opiate-withdrawn mice.

Piccin A, Contarino A. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 8;97:109780.

 

Chronic exposure to cocaine is associated with persistent behavioral disturbances. A cross-sectional dimensional study in outpatients with multiple substance use disorders.

Vorspan F, de Witt P, Zerdazi EH, Karsinti E, Ksouda K, Icick R, Bellivier F, Marie N, Brousse G, Bloch V. Psychopharmacology (Berl). 2020 Nov;237(11):3399-3407.

 

Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress.

Corne R, Besson V, Ait Si Slimane S, Coutan M, Palhas MLC, Shen FX, Marchand-Leroux C, Ogier M, Mongeau R. Neuroscience. 2021 Jul 1;466:205-221.

 

Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine.

Dallérac G, Li X, Lecouflet P, Morisot N, Sacchi S, Asselot R, Pham TH, Potier B, Watson DJG, Schmidt S, Levasseur G, Fossat P, Besedin A, Rivet JM, Coyle JT, Collo G, Pollegioni L, Kehr J, Galante M, Fone KC, Gardier AM, Freret T, Contarino A, Millan MJ, Mothet JP. Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):e2023750118.

 

Evaluation of Specific Binding of [11C]RTI-97 to Kappa Opioid Receptor by Autoradiography and PET Imaging in Rat.

Fillesoye F, Ibazizène M, Marie N, Noble F, Perrio C. ACS Med Chem Lett. 2021 Oct 19;12(11):1739-1744.

 

Antioxidant Activity and Toxicity Study of Cerium Oxide Nanoparticles Stabilized with Innovative Functional Copolymers.

Goujon G, Baldim V, Roques C, Bia N, Seguin J, Palmier B, Graillot A, Loubat C, Mignet N, Margaill I, Berret JF, Beray-Berthat V. Adv Healthc Mater. 2021 Jun;10(11) ):e2100059.

 

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.

Munn-Chernoff MA, et al. Genetics Working Group (Pantel J) Addict Biol. 2021 Jan;26(1):e12880.

 

Biased Opioid Ligands: Revolution or Evolution?

Noble F, Marie N. Front Pain Res (Lausanne). 2021 Sep 24;2:722820.

 

Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity.

Wu Z, Stadler N, Abbaci A, Liu J, Boullier A, Marie N, Biondi O, Moldes M, Morichon R, Feve B, Melander O, Forgez P. Front Endocrinol (Lausanne). 2021 Oct 8;12:739287.

 

Common Genetic Variation and Age of Onset of Anorexia Nervosa.

Watson HJ, et al., Genetics Working Group (Pantel J) Biol Psychiatry Glob Open Sci. 2021 Sep 20;2(4):368-378.

 

Inhibition of striatal SEZ6 by miR-3594-5p is a drug-specific marker for late-stage heroin intake escalation

Lenoir M., Bondi I., Clemenceau L., Nondier I., Ballé M., Jacques S., Duché A., Saintpierre B., Canestrelli C., Martin-Lannerée S., Mouillet-Richard S., Gunnersen J.M., Ahmed S.H., Marie N., Noble F. (2021) (https://biorxiv.org/cgi/content/short/2021.07.26.453355v1).

 

Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.

Leconte C, Mongeau R, Noble F. Front Pharmacol. 2022 Apr 27;13:856672.

 

Morphine reduces the interest for natural rewards.

Piccin A, Courtand G, Contarino A. Psychopharmacology (Berl). 2022 Aug;239(8):2407-2419.

 

The CRF1 receptor mediates social behavior deficits induced by opiate withdrawal.

Piccin A, Contarino A. J Neurosci Res. 2022 Jan;100(1):309-321.

 

Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects

Requana Aradas A, Djaboub Y, McCort-Tranchepain I, Hajasova Z, Clémenceau L, Canestrelli C, Mann A, Schulz S, Delaval A, Acher F, Massotte D, Noble F, Marie N. Int J Neuropsychopharmacol. 2023 Jul; 26(7): 513–521.

 

Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans?

Delage C, Morel A, de Witt P, Jauffret-Roustide M, Bloch V, Noble F, Vorspan F, Marie N. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Dec 20;127:110824.

 

Oxycodone, an opioid like the others?

Marie N, Noble F. Front Psychiatry. 2023 Dec 13;14:122943.